ArticleJournal of applied toxicology : JAT2026
Zinc Oxide Nanoparticles' Acute and Subacute Oral Toxic Effects on Pancreas in Adult Male Albino Rats.
Article in Journal of applied toxicology : JAT, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Zinc oxide nanoparticles (ZnO-NPs) are being progressively employed in various industries, including cosmetics, textiles, and sun protection products. Due to their widespread application, concerns have emerged about their potential health hazards, especially through environmental exposure. This study was conducted to assess the acute and subacute toxicological impact of orally administered ZnO-NPs (30 ± 5 nm) on the pancreas of adult male albino rats. In this study, the size of ZnO-NPs was determined by using transmission electron microscopy (TEM) as provided by the company. Eighty male albino rats (2.5-3 months old) were allocated into two equal groups to evaluate acute (1 day) and subacute (28 days) ZnO-NP toxicity (40 rats each). Each was further divided into control (negative and positive), low-dose (175 mg/kg), and high-dose (350 mg/kg) subgroups. Blood was collected via cardiac puncture under anesthesia for biochemical analysis, and pancreatic tissues were examined histopathologically and immunohistochemically. Both acute and subacute ZnO-NP exposure caused a significant rise in blood glucose and serum Zn. Insulin levels increased acutely but decreased with subacute exposure. The subacute group showed a significant increase in oxidative stress markers indicated by elevated malondialdehyde (MDA) compared to controls. Histological examination revealed pancreatic degeneration, whereas increased inducible nitric oxide synthase (iNOS) immunopositivity indicated an inflammatory response, suggesting the involvement of oxidative stress in both groups. Oral exposure to toxic doses of ZnO-NPs caused oxidative stress and structural damage in pancreatic cells, affecting insulin and glucose levels. These findings highlight the potential health risks of ZnO-NP exposure, particularly with prolonged use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.